Ceftin

Impetigo, Maxillary Sinusitis, Bacterial Meningitis + 17 more

Treatment

2 FDA approvals

20 Active Studies for Ceftin

What is Ceftin

Cefuroxime

The Generic name of this drug

Treatment Summary

Cephalosporin is an antibiotic used to fight a wide range of bacterial infections, including those caused by gram-positive and gram-negative bacteria, gonorrhea, and Haemophilus. It is resistant to beta-lactamase, which is an enzyme produced by bacteria that can make antibiotics less effective.

Zinacef

is the brand name

image of different drug pills on a surface

Ceftin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Zinacef

Cefuroxime

1989

163

Approved as Treatment by the FDA

Cefuroxime, commonly known as Zinacef, is approved by the FDA for 2 uses such as Bacterial Infections and Urinary Tract Infection (UTI) .

Bacterial Infections

Urinary Tract Infection (UTI)

Effectiveness

How Ceftin Affects Patients

Cefuroxime is an antibiotic that interferes with the growth of certain bacteria. It works by blocking the formation of the walls that surround and protect the bacteria, which kills them. Cefuroxime is effective against bacteria like Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Borrelia burgdorferi. Cefuroxime ax

How Ceftin works in the body

Cefuroxime works like penicillins. It attaches to proteins inside bacteria cells and stops the bacteria from making their cell walls. This leads to the breakdown of the cells, killing them. It may also prevent the bacteria from making an enzyme that stops cell breakdown.

When to interrupt dosage

The prescribed amount of Ceftin is contingent upon the identified ailment, including Gonorrhea, Urinary Tract Infection (UTI) and Bone and Joint Infections. The sum of dosage is determined by the methodology of delivery (e.g. Intravenous or Tablet, film coated) as specified in the table below.

Condition

Dosage

Administration

Maxillary Sinusitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

prophylaxis of infection in minor cuts, scrapes, or burns

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Animal bite

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bacterial Infections

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

mild Streptococcal pharyngitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

moderate Streptococcal tonsillitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Urinary Tract Infections

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Osteomyelitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bronchitis, Chronic

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Otitis Media

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Tonsillitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Septicemia

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Urinary Tract Infection (UTI)

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Impetigo

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bacterial Meningitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

moderate Streptococcal pharyngitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Operative Surgery

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Gonorrhea

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Lyme Disease

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Bronchitis

, 1500.0 mg, 750.0 mg, 7500.0 mg, 750.0 mg/mL, 90.0 mg/mL, 500.0 mg, 250.0 mg, 150.0 mg/mL, 7.5 mg/mL, 15.0 mg/mL, 250.0 mg/mL, 125.0 mg, 125.0 mg/mL, 75000.0 mg, 225000.0 mg, 95.0 mg/mL, 75.0 mg/mL

, Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Injection, solution, Injection, solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Suspension, Suspension - Oral, Powder, for solution, Powder, for solution - Oral, Powder, for solution - Intravenous, Powder, for solution - Intramuscular; Intravenous, Powder, Powder - Oral, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Granule, for suspension - Oral, Granule, for suspension

Warnings

Ceftin Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Ceftin.

Common Ceftin Drug Interactions

Drug Name

Risk Level

Description

Neomycin

Major

The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Neomycin.

Tenofovir

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir.

Tenofovir alafenamide

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir alafenamide.

Tenofovir disoproxil

Major

Cefuroxime may increase the nephrotoxic activities of Tenofovir disoproxil.

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefuroxime.

Ceftin Toxicity & Overdose Risk

An allergic reaction to cephalosporins may include rash, stuffy nose, coughing, sore throat, itchy eyes, or a severe life-threatening reaction known as anaphylaxis. Taking too much of this medication can also cause headaches and seizures.

image of a doctor in a lab doing drug, clinical research

Ceftin Novel Uses: Which Conditions Have a Clinical Trial Featuring Ceftin?

At present, 146 active trials are in progress to assess the potential of Ceftin in providing moderate Streptococcal pharyngitis relief, treating Bacterial Infections and Animal bite.

Condition

Clinical Trials

Trial Phases

Gonorrhea

0 Actively Recruiting

Operative Surgery

70 Actively Recruiting

Phase 3, Not Applicable, Phase 4, Phase 1, Phase 2, Early Phase 1

moderate Streptococcal pharyngitis

0 Actively Recruiting

prophylaxis of infection in minor cuts, scrapes, or burns

0 Actively Recruiting

Maxillary Sinusitis

0 Actively Recruiting

Septicemia

1 Actively Recruiting

Not Applicable

Tonsillitis

0 Actively Recruiting

Bronchitis, Chronic

0 Actively Recruiting

moderate Streptococcal tonsillitis

0 Actively Recruiting

Bronchitis

1 Actively Recruiting

Not Applicable

Lyme Disease

5 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Phase 3

Bacterial Meningitis

0 Actively Recruiting

Animal bite

0 Actively Recruiting

Otitis Media

0 Actively Recruiting

Impetigo

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

mild Streptococcal pharyngitis

0 Actively Recruiting

Urinary Tract Infections

11 Actively Recruiting

Not Applicable, Phase 4, Early Phase 1

Osteomyelitis

0 Actively Recruiting

Urinary Tract Infection (UTI)

8 Actively Recruiting

Phase 1, Phase 3, Phase 4, Not Applicable, Phase 2

Ceftin Reviews: What are patients saying about Ceftin?

5

Patient Review

12/22/2013

Ceftin for Bacterial Urinary Tract Infection

Ceftin is the only antibiotic that doesn't make my chronic constipation worse, and I really appreciate that. It's also helped me avoid other problems, like yeast infections, that come with taking other antibiotics.

5

Patient Review

12/31/2015

Ceftin for Acute Maxillary Sinus H. Influenzae Bacteria Infection

I took 500mg twice daily for 10 days as directed. I felt great at day 7 and had no issues with the medication - results were great!

5

Patient Review

12/3/2018

Ceftin for Lyme Disease

I've been on this medication for almost a month now, and was initially worried about side effects. The worst one I've experienced is constipation, but it seems to be helping with my Lyme disease symptoms. I take 500mg twice a day, and have had no problems tolerating it on an empty stomach.

4.7

Patient Review

6/25/2013

Ceftin for Bacterial Urinary Tract Infection

I generally have a lot of anxiety and negative side effects when taking antibiotics, but this medication was different. It didn't make me feel as bad. The taste is really gross when swallowing it, but i had no other side effects. I was prescribed to take 2 pills a day for 3 days and i felt better by the second day but i finished all 6 pills.

4.7

Patient Review

3/28/2015

Ceftin for Strep Throat and Tonsillitis

Despite the terrible taste, I'm really glad I took this medication. I woke up feeling great after the first dose, and my back pain (which has been constant since spinal surgery four months ago) completely disappeared. I highly recommend it to anyone in a similar situation!

4.7

Patient Review

5/27/2017

Ceftin for Urinary Tract Infection due to E. Coli Bacteria

There aren't many options available to me as I'm allergic to Macrobid and Bactrim, but Cipro really did the trick in getting rid of my infection. The generic form doesn't have a terrible taste, which is great. As with any antibiotic, make sure you take it with food and drink lots of water while you're taking the medication.

4.3

Patient Review

6/5/2015

Ceftin for Pneumonia caused by Bacteria

I think this medicine is helping with my bronchitis, though I can't be sure. What I do know is that it's giving me serious insomnia, which is something I've never struggled with before.

4

Patient Review

5/27/2015

Ceftin for Middle Ear Infection

I was prescribed 500mg Ceftin 2x/day for 10 days for an ear infection. I lost all sense of taste and smell for the entire ten days except for a stong chemical taste on my tongue. My last dose was 15 hours ago and I have just gotten back a small sense of smell. I was also extremely fatigued the entire time.

4

Patient Review

5/26/2017

Ceftin for Urinary Tract Infection due to E. Coli Bacteria

I found that I can take this one, even though I'm allergic to most of the main antibiotics used for urinary tract infections. The generic does not have the horrible taste, but you must take it with food and drink plenty of water. I hate taking it because it makes me feel awful at first, but then after a few days, I get used to it. It does help my urinary tract infections.

3.7

Patient Review

5/31/2013

Ceftin for Bacterial Urinary Tract Infection

I had a UTI and it was awful. The taste is really bad, and it's expensive without insurance. I was scared to take it at first because of the side effects, but none of them happened. However, I did have bad stomach pain afterwards so I took it with water and yogurt to help with the pain and taste. Overall, it helped me get rid of my UTI.

2.3

Patient Review

3/6/2014

Ceftin for Acute Maxillary Sinus H. Influenzae Bacteria Infection

This medication was ineffective in treating my sinus infection, as well as those of friends and family members. I am concerned that this drug is being marketed as effective when it so clearly is not.

2.3

Patient Review

6/13/2013

Ceftin for Bacterial Pneumonia caused by Streptococcus

Not only was this medicine ineffective, but it actually made my blood sugar level rise and gave me mouth thrush.

2.3

Patient Review

3/15/2015

Ceftin for Bacterial Infection with Chronic Bronchitis

I was prescribed this medication for a cough and cold. However, I ended up with a terrible case of 'C diff' colitis. Now, I'm on Flagyl to clear the infection up. I hope I never have to take another antibiotic again!

1.7

Patient Review

5/9/2013

Ceftin for Middle Ear Infection

I'm still experiencing symptoms even after a week of treatment.

1.7

Patient Review

4/8/2021

Ceftin for Pneumonia caused by Bacteria

I took this for pneumonia and it only made things worse. I felt extremely confused, nauseous, and had a terrible headache on top of the other effects listed in the title.

1.7

Patient Review

7/16/2014

Ceftin for Strep Throat

I was diagnosed with strep throat and prescribed this medication. I experienced no relief after the recommended five days, and the taste is incredibly unpleasant. Overall, a very negative experience.

1

Patient Review

4/30/2014

Ceftin for Urinary Tract Infection caused by Klebsiella Bacteria

Blurry vision, burning while urinating, nausea, and upset stomach are just some of the issues I had while taking this medication. My doctor prescribed it for a month, 500mg twice daily.

1

Patient Review

12/14/2013

Ceftin for Acute Inflammation of the Maxillary Sinus

Unfortunately, this medication made me feel worse rather than better. The side effects were really unpleasant and not worth it.

1

Patient Review

8/8/2016

Ceftin for Urinary Tract Infection due to E. Coli Bacteria

I had a urine test done by a lab tech, who found bacteria in the urine - E.coli. I took 2 pills a day for 5 days, at which time I stopped because I had vaginal bleeding. Since then, I have been having severe urinary tract infection.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ceftin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug Ceftin used to treat?

"It will not work for viral infections (such as common cold, flu).

Cefuroxime is used to treat a variety of bacterial infections. This medication is a cephalosporin antibiotic and works by stopping the growth of bacteria. This antibiotic only treats bacterial infections and will not work for viral infections."

Answered by AI

Is Ceftin and Cipro the same?

"The study found that ciprofloxacin and cefuroxime axetil were both effective in treating community-acquired acute sinusitis, with similar rates of bacteriologic eradication at the end of therapy. Both treatments were well tolerated."

Answered by AI

Is Ceftin in the penicillin family?

"Amoxicillin and Ceftin are two different types of antibiotics. Amoxicillin is a penicillin-type antibiotic, while Ceftin is a cephalosporin antibiotic. Both medications can cause side effects like diarrhea, abdominal pain, nausea, vomiting, and rash. Allergic reactions are also possible with both amoxicillin and Ceftin."

Answered by AI

Is cefuroxime stronger than amoxicillin?

"Our results showed that cefuroxime axetil given twice a day was just as effective in treating acute bacterial maxillary sinusitis as amoxicillin/clavulanate given three times a day, but cefuroxime axetil caused fewer side effects."

Answered by AI

Clinical Trials for Ceftin

Image of Ohio University in Athens, United States.

Virtual Reality for Medical Training

18+
All Sexes
Athens, OH

As the U.S. population ages, future physicians must be prepared to care for older adults with multiple health conditions and complex needs. This study will test whether cinematic virtual reality (VR)-an immersive, interactive learning tool-is more effective than traditional lectures in helping medical students learn about geriatric care. Students who complete the VR training will experience realistic patient scenarios that show what can go wrong in medical care and learn how to apply osteopathic principles to improve outcomes. Researchers will compare students' performance on a clinical skills assessment and explore their experiences with the VR training. The goal is to determine whether cinematic virtual reality can better prepare students for residency and improve their ability to provide compassionate, high-quality care for older adults.

Recruiting
Has No Placebo

Ohio University

Elizabeth A Beverly, PhD

Have you considered Ceftin clinical trials?

We made a collection of clinical trials featuring Ceftin, we think they might fit your search criteria.
Go to Trials
Image of Northern Light Eastern Maine Medical Center in Bangor, United States.

VLA15 Vaccine for Lyme Disease

Any Age
All Sexes
Bangor, ME

The purpose of this study is to learn about the safety effects of the Lyme disease vaccine (called VLA15), and its ability to protect people from Lyme disease after a 5th dose of the vaccine. This study is seeking participants who: * are generally healthy and 7 years of age and older, * have already been vaccinated with 4 doses of VLA15 (from the VALOR study), and have blood sample taken post dose 4. * are not currently taking, or haven't recently taken, medicines like chemotherapy, blood products, or blood thinners. * are not pregnant or breastfeeding and do not plan to become pregnant while receiving the study vaccine. All participants in this study will receive a total of 1 dose through a shot in the upper arm, either VLA15 or saline shot (saltwater). The study will compare the experiences of people receiving the study vaccine or saltwater shot. Participants will take part in this study for about 12 months. During this time, they will have 4 planned clinic visits. The clinic visits may include having a health check, giving a small amount of blood and getting the study vaccine or saltwater as a shot at the first visit.

Phase 3
Recruiting

Northern Light Eastern Maine Medical Center (+21 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of UW Health in Madison, United States.

Automated vs Specialist-Delivered Training for Surgery

18+
All Sexes
Madison, WI

This study evaluates strategies to train surgeons to use Better Conversations, an evidence-based communication framework designed to improve informed consent by helping patients understand the goals of surgery, the downsides of treatment, and what to expect. Better Conversations supports deliberation, patient preparation, and alignment of decisions with patient goals, addressing known shortcomings in traditional informed consent. The purpose of this study is to compare two methods of surgeon training: (1) training delivered by an education specialist using audit and feedback, and (2) training supported by computerized automation that identifies elements of Better Conversations in de-identified transcripts of surgical consultations. The central question is whether the automated training program is non-inferior to the specialist-delivered program. Approximately 60 surgeons from two academic health systems will be randomized to one of these training approaches. Each surgeon will complete a didactic session, have outpatient surgical consultations audio-recorded for feedback, and complete assessment recordings after training. Patients of enrolled surgeons will complete surveys before and after their surgeon's training to evaluate patient-reported communication outcomes. Findings from this study will assess the effectiveness, feasibility, and acceptability of automated training and support the development of a larger pragmatic study to evaluate the broader effects of Better Conversations on patient outcomes.

Waitlist Available
Has No Placebo

UW Health (+1 Sites)

Margaret (Gretchen) L Schwarze, MD, MPP

Have you considered Ceftin clinical trials?

We made a collection of clinical trials featuring Ceftin, we think they might fit your search criteria.
Go to Trials
Image of Children's of Alabama in Birmingham, United States.

Antibiotic Duration for Infections in Children

60 - 17
All Sexes
Birmingham, AL

Infections like pneumonia, skin and soft tissue infection (also called SSTI or cellulitis), and urinary tract infections (UTI) are some of the most common reasons children get admitted to the hospital. All three of these conditions require antibiotics for treatment. Although antibiotics are needed to treat the infection and help children feel better, taking them longer than needed can negatively impact children and their families. Negative impacts include things like the burdens of taking more medications and medication side effects. There are guidelines (instructions) from expert medical organizations that suggest the number of days children need antibiotics, but they give a wide range (between 5 and 14 days). Unfortunately, these guidelines are not based on high-quality studies. National data suggests that doctors often choose on the higher end of this range when writing prescriptions for children in the hospital. Our three caregiver co-investigators, other parents of hospitalized children, doctors, other care providers, and researchers, all believe that additional study is needed to determine the best length of antibiotic treatment that weighs both the benefits and harms of antibiotics. The goal of our study is to understand if 5 total days of antibiotic treatment compared to 10 total days of antibiotic treatment is better for children who have been in the hospital for pneumonia, SSTI, or UTI. We will study this question through a randomized control trial. In other words, half of the children will receive 5-days of antibiotics and the other half will receive 10-days of antibiotics. Children in this study (and their caregivers) will not know how many days of antibiotics they will receive to cure their infection because some children will take a placebo (or a pill without antibiotics in it). Only the pharmacy will know if a child is getting antibiotic or placebo (for days 6-10 of treatment). During the first phase of the trial (feasibility phase), 4 hospitals will enroll children in the study. We plan on enrolling 50 patients during this phase. We are starting with just 4 hospitals, so our study team can create and update our study plans if needed. We will closely review information about how many patients and families agree to participate, and if they have any trouble completing any part of the study. We will also interview families to understand the choice to participate in the study, the choice not to participate in the study, and what it is like to be in the study. During the second study phase, we will enroll 1150 more patients across all 11 hospitals. Families will complete short, daily surveys until the 15th day after they started antibiotics, then a larger survey at day 15, at day 20, and at day 30. These surveys will ask about the child's symptoms and recovery from their illness, how the antibiotics are making them feel, and if they had to go back to their doctor, emergency room, or hospital. The answers to these questions will be combined to measure how well the child did, balancing feeling better and having bad effects from the antibiotics. We will use mathematical tests to determine which antibiotic duration is better for treating these illnesses. We will complete other mathematical tests to see if all children should receive the same length of antibiotics or if certain children should be prescribed shorter courses and others longer courses.

Phase 4
Waitlist Available

Children's of Alabama (+9 Sites)

Sunitha V Kaiser, MD, MSc

Image of Medstar National Rehabilitation Hospital in Washington D.C., United States.

Lactobacillus Crispatus for Urinary Tract Infection

18+
All Sexes
Washington D.C., United States

The goal of this clinical trial is to determine whether Lactobacillus crispatus strains isolated from the lower urinary tracts of adult women can be used as an antibiotic-sparing treatment for urinary symptoms and urinary tract infection (UTI) among adults with neurogenic lower urinary tract dysfunction (NLUTD). The main question\[s\] it aims to answer are: 1. To identify soluble bactericidal compounds produced by urinary isolates of L. crispatus that kill uropathogenic E. coli (UPEC). 2. To determine if intravesical instillation of L. crispatus is safe and well tolerated in adults with NLUTD due to SCI who use intermittent catheterization (IC). If there is a comparison group: Researchers will compare L. Crispatus to standard care saline to see if there is a difference in urinary symptoms and urinary microbiome. Participants will be asked to complete daily symptom surveys, complete 2 bladder instillations, and collect, freeze, and return 14 urine samples.

Phase < 1
Recruiting

Medstar National Rehabilitation Hospital

Suzanne Groah, MD

Image of Direct Helpers in Hialeah, United States.

Rifaximin + ORT for Diarrhea

6 - 12
All Sexes
Hialeah, FL

The goal of this clinical trial is to learn how rifaximin 200 mg is processed in the body (pharmacokinetics) in children 6 to 11 years old with acute diarrhea that may be caused by bacteria. It will also learn about the safety and effectiveness of rifaximin when given with oral rehydration therapy (ORT) compared with ORT alone. The main questions it aims to answer are: How does rifaximin 200 mg move through and leave the body in children with acute diarrhea? Is rifaximin safe for children in this age group? Does rifaximin plus ORT help resolve diarrhea faster than ORT alone? Researchers will compare rifaximin plus ORT to ORT alone to see if adding rifaximin improves outcomes. Participants will: Take one rifaximin 200 mg tablet + ORT three times a day for 3 days or receive ORT alone Receive oral rehydration therapy according to the investigator's standard of care Attend up to 4 clinic visits over 5 days and receive 4 follow-up phone calls Provide blood samples on Day 1 and Day 3 for pharmacokinetic testing (rifaximin group only) Provide stool samples to identify bacterial pathogens Keep a diary of stool frequency and consistency to help determine when diarrhea resolves Be monitored for side effects, vital signs, and laboratory changes

Phase 4
Recruiting

Direct Helpers (+4 Sites)

Bausch Health Americas, Inc.

Have you considered Ceftin clinical trials?

We made a collection of clinical trials featuring Ceftin, we think they might fit your search criteria.
Go to Trials